Tag: field

CAMBRIDGE, Mass., June 27, 2025 (GLOBE NEWSWIRE) -- Biogen Inc. (Nasdaq: BIIB) today announced new data that reinforce the clinical impact of nusinersen across a broad spectrum of individuals affected by spinal muscular atrophy (SMA). These latest findings from Part C of the DEVOTE trial evaluating a higher dose regimen of nusinersen and the NURTURE trial which evaluated the approved 12 mg regimen (SPINRAZA^®) in clinically presymptomatic SMA were presented at the SMA Research & Clinical Care Meeting hosted by Cure SMA in Anaheim, Calif. Biogen’s applications for the higher dose regimen of nusinersen are currently under review in the U.S., Europe, Japan and other global markets. The higher dose regimen of nusinersen comprises a more rapid loading regimen – two 50 mg doses 14 days apart – and a higher maintenance regimen – 28 mg every four months.

VALENCIA, Spain, June 27, 2025 (GLOBE NEWSWIRE) -- Turbo Energy, S.A. (NASDAQ:TURB) (“Turbo Energy” or the “Company”), a leader in the field of photovoltaic energy storage, today announced that the following resolutions were approved at its 2025 Annual General Meeting of Shareholders held on June 24, 2024 in Valencia, Spain:

CALGARY, Alberta, June 26, 2025 (GLOBE NEWSWIRE) -- Acceleware^® Ltd. (“Acceleware” or the “Company”) (TSX-V: AXE), is pleased to announce it has entered into an agreement (the “Marwayne Agreement”) with O’Neill Industries International-Canada Inc. (“O’Neill Canada”) that will result in the transfer of certain wells and other assets located in Marwayne, Alberta, related liabilities, licenses and leases from Acceleware to O’Neill Canada, and the termination of the existing farmout and option agreement dated May 19, 2020 between the Company and O’Neill Canada. O’Neill Canada is the Canadian entity of O’Neill Industries, a US based company active in upstream production and oil field services globally. In exchange for the above noted transfers, Acceleware will receive cash payments and a gross overriding royalty (“GORR”) on future production from the wells as described below. The Marwayne Agreement sets the stage for renewed collaboration between the Company and O’Neill Canada that includes a commitment to establish a new farmout agreement at Marwayne where Acceleware can drill new RF XL 2.0 compliant test wells in the next five years.

EVA Pharma Deepens Its Roots in China’s Thriving Biopharmaceutical Ecosystem with The Inauguration of Its Hangzhou Office